14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Fri, 3 May 2024

NMTR Predictions History

1 year ago
AlexVel predicted that NMTR for 2022-06-22 is going $0.322 (21.49%)

1 year ago
JS predicted that NMTR for 2022-06-22 is going $0.331 (24.95%)

2 years ago
JS predicted that NMTR for 2021-07-22 is going $1.19 (0.85%)

2 years ago
JS predicted that NMTR for 2021-05-21 is going $1.21 (0.83%)

2 years ago
Paul Cridlin predicted that NMTR for 2021-05-21 is going

Rank:

3 years ago
JS predicted that NMTR for 2021-04-14 is going $1.14 (-2.56%)

3 years ago
JS predicted that NMTR for 2021-03-18 is going $1.65 (0.00%)

3 years ago
jjsheets330 predicted that NMTR for 2021-03-18 is going $6.00 (255.03%)

3 years ago
Barry Collett predicted that NMTR for 2021-03-18 is going

Rank:

3 years ago
JS predicted that NMTR for 2021-03-01 is going $1.71 (-1.72%)

Click to get the best stock tips daily for free!

About 9 Meters Biopharma, Inc.

9 Meters Biopharma. 9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as well as in Phase IIa clinical trial for treatment of multi-system inflammatory syndrome; and Vurolenatide... NMTR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT